Antiphospholipid syndrome epidemiology and demographics: Difference between revisions
Feham Tariq (talk | contribs) |
Feham Tariq (talk | contribs) |
||
| Line 8: | Line 8: | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of antiphospholipid syndrome (APS) is approximately 5 cases per 100,000 persons per year. | *The incidence of antiphospholipid syndrome (APS) is approximately 5 cases per 100,000 persons per year. | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of APS is approximately 40-50 cases per 100,000 persons worldwide. | *The prevalence of APS is approximately 40-50 cases per 100,000 persons worldwide. | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
| Line 30: | Line 27: | ||
===Region=== | ===Region=== | ||
*There is no particular regional predilection. | *There is no particular regional predilection. | ||
===Developed Countries=== | ===Developed Countries=== | ||
Revision as of 00:22, 12 April 2018
|
Antiphospholipid syndrome Microchapters |
|
Differentiating Antiphospholipid syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Antiphospholipid syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Antiphospholipid syndrome epidemiology and demographics |
|
FDA on Antiphospholipid syndrome epidemiology and demographics |
|
CDC on Antiphospholipid syndrome epidemiology and demographics |
|
Antiphospholipid syndrome epidemiology and demographics in the news |
|
Blogs on Antiphospholipid syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Antiphospholipid syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
Epidemiology and Demographics
Incidence
- The incidence of antiphospholipid syndrome (APS) is approximately 5 cases per 100,000 persons per year.
Prevalence
- The prevalence of APS is approximately 40-50 cases per 100,000 persons worldwide.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- The commonly affected age groups are young to middle aged adolescents.
- However, APS is also seen in children and elderly age group.
Race
- APS due to systemic lupus erythermatosus(SLE) is more commonly seen in the African American and Hispanic population.
Gender
- Middle aged women are more commonly affected by APS than males.
Region
- There is no particular regional predilection.